260 related articles for article (PubMed ID: 8767033)
21. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
Nkam I; Langlois-Thery S; Dollfus S; Petit M
Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
[TBL] [Abstract][Full Text] [Related]
22. Do neuroleptics cause depression?
Roy A
Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
[TBL] [Abstract][Full Text] [Related]
23. Negative symptoms of schizophrenia: a problem that will not go away.
Stahl SM; Buckley PF
Acta Psychiatr Scand; 2007 Jan; 115(1):4-11. PubMed ID: 17201860
[TBL] [Abstract][Full Text] [Related]
24. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
Kahn JP
Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
[TBL] [Abstract][Full Text] [Related]
25. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
Fleischhaker C; Schulz E; Remschmidt H
Z Kinder Jugendpsychiatr Psychother; 1998 Dec; 26(4):235-43. PubMed ID: 9880833
[TBL] [Abstract][Full Text] [Related]
26. ["Primary and secondary negative symptoms: a reliable differentiation?" Comment on the contribution by W. Barnett et al].
Amminger GP; Kirkpatrick B
Nervenarzt; 1997 May; 68(5):438-40. PubMed ID: 9280857
[No Abstract] [Full Text] [Related]
27. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
[TBL] [Abstract][Full Text] [Related]
28. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Buis C; Gourion D; Vaiva G
Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
[No Abstract] [Full Text] [Related]
29. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
30. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
Himelhoch S; Taylor SF; Goldman RS; Tandon R
Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
[No Abstract] [Full Text] [Related]
31. Perspectives on treatment needs in schizophrenia.
Meise U; Fleischhacker WW
Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
[No Abstract] [Full Text] [Related]
32. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.
Suzuki E; Kanba S; Koshikawa H; Nibuya M; Yagi G; Asai M
J Psychiatry Neurosci; 1996 May; 21(3):167-71. PubMed ID: 8935328
[TBL] [Abstract][Full Text] [Related]
33. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
Naber D; Lambert M; Karow A
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
[TBL] [Abstract][Full Text] [Related]
34. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
[TBL] [Abstract][Full Text] [Related]
35. Treating negative symptoms.
Bailey P; Duval F; Macher JP
Br J Psychiatry; 1994 May; 164(5):699-700. PubMed ID: 7921730
[No Abstract] [Full Text] [Related]
36. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
Dassa D; Lacambre M; Vacheron MN
Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
[No Abstract] [Full Text] [Related]
37. The Psychiatric Symptom Assessment Scale (PSAS).
Bigelow LB; Berthot BD
Psychopharmacol Bull; 1989; 25(2):168-73. PubMed ID: 2574891
[No Abstract] [Full Text] [Related]
38. [Stability of positive/negative symptoms in schizophrenia].
Ribeyre JM; Dollfus S
Encephale; 1996 Jun; 22 Spec No 2():29-31. PubMed ID: 8767039
[TBL] [Abstract][Full Text] [Related]
39. [Schizophrenia: receptors and clinical aspects].
Azorin JM
Encephale; 1997 Apr; 23 Spec No 2():17-9. PubMed ID: 9273301
[TBL] [Abstract][Full Text] [Related]
40. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
